Ability to execute - that is a key question; when to

New Post Public Reply Private Reply Replies (0) Message Board
Ulf53
786
Ability to execute - that is a key question; when to consider the opportunity and looking at risk/reward ratio, we all have our way to evaluate a stock investment. This community gives us a chance to find stocks - and learn from each other.


QBL; how shall one look at a mining company turn to medical marijuana ? I found out, they are not the first. The Feldmans (management) was approached by Canntab Therapeutics Limited (“Canntab”) of Toronto, Ontario, Canada. Reason ? See below.


They have -" The company also pursues additional investment opportunities, and has acquired a 55% shareholding in Medical Cannabis Limited, an Australian leader in the hemp and Cannabis industries." (3 entities working as one, with cross ownership)


Some businesses within the cannabis industry, have started out with other ideas. When so this gigantic business is growing fast, they adapt and "catch the moment" when they see the good opportunity. QBL investment in Medical Cannabis Ltd, paved the way to get this serious offer from respected canadian Canntab Therapeutics.


Some plus; they are globally oriented, with Australia as home base/market. Connected with the canadian market threw there JV, will help growth/value and add know-how to the company.
The connection to Israel is also of importance in the story, as it is the leader in cannabis scientific knowledge and experience.


The questions; how well are they to be able; execute from seed to product to sales ? What are there masterplan with the hemp, cannabis and bauxite in the long run ? To get the "big money" from investors, they must continue work on explaining the businessmodel.


Conclusion; there is a exciting chance now, I want to see how they can get it be offically cleared as cutting edge products - and communicate it within the industry. Investors and other customers must know QBL master the regulatory framework. Get full pharma-grade approval (eventually) on a global scale, then we sit on first row.



Read More: https://investorshangout.com/post/view?id=491...z54p5kmWmR
Robert
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Albion Enterprise VCT PLC Boosts Equity with New Share Allotment

Updated Category News Views 202

Albion Enterprise VCT PLC Enhances Its Equity Portfolio Albion Enterprise VCT PLC (LSE: AAEV) has recently made a significant move to bolster its equity by issuing new shares. This decision aligns with the company’s commitment to expanding its capital while providing opportunities for shareholders through its Dividend Reinvestment Scheme. Details of the New Share...

Continue Reading
Capsida Biotherapeutics and AbbVie's Collaboration Milestones

Updated Category News Views 215

Capsida's Recent Advances in Genetic Medicine Capsida Biotherapeutics has made a remarkable stride by partnering with AbbVie to combat neurodegenerative diseases, a step that marks a significant achievement in the realm of genetic medicine. The collaboration has evolved, leading to AbbVie exercising its option on the first neurodegenerative disease program, which...

Continue Reading
AB Amber Grid Sees Decrease in Revenue Yet Growth in Profitability

Updated Category News Views 239

AB Amber Grid's 2024 Operating Results Overview AB Amber Grid has published its unaudited financial results for the year 2024, reflecting the company’s performance in accordance with the International Financial Reporting Standards. With a focus on strategic growth, the company demonstrated robust management despite challenges in the market. Financial Performance...

Continue Reading
Linkage Global Secures $1 Million in Private Placement Financing

Updated Category News Views 245

Linkage Global Inc. Closes $1 Million Private Placement Financing Linkage Global Inc (NASDAQ: LGCB), a leading cross-border e-commerce service provider based in Japan, has successfully completed a private placement financing that raised $1 million. This announcement marks a significant milestone for the company as it continues to enhance its financial foundation. Details...

Continue Reading
Amedisys and UnitedHealth Merger Update: What to Expect

Updated Category News Views 781

Understanding the Amedisys and UnitedHealth Merger Situation Amedisys Inc (NASDAQ: AMED) has seen its shares rise as the company announces an extension to its merger deadline with UnitedHealth Group Incorporated (NYSE: UNH). This unexpected turn of events has grabbed the attention of investors and industry watchers alike. What Is the Merger About? The proposed merger...

Continue Reading